Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Nuvalent, Inc ...
Nuvalent shares soar as GSK announces a $10.6 billion buyout deal. But is it too late already to invest in NUVL stock?
/The%20Cerebras%20logo%20displayed%20on%20a%20smartphone%20screen%20by%20Rafael%20Henrique%20via%20Shutterstock.jpeg)
The Cerebras IPO is the most significant debut in the semiconductor industry since Arm.
On-screen parenting duo stars in new, original video highlighting relatable parenting moments, educating viewers about meningococcal disease, also known as meningitis GSK’s Ask2BSure...
Big Pharma stalwarts AbbVie, AstraZeneca, and GSK beat Q1 revenue expectations, raising guidance and offering a potential tailwind for the flailing medical sector.
Barchart Research What to Expect from GSK Earnings GSK Generated April 28, 2026 Current Price $54.47 EPS Estimate $$1.17 Consensus Rating Hold Average Move 4.32% GSK's Vaccine Momentum Meets the HIV Patent...
Three low P/E small-cap stocks offer distinct catalysts and upside potential as investors look ahead to a broader market rally
In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection 1 *
Bora manufactures more than 20 commercial products for GSK at its Mississauga facility, supporting infectious disease, mental health, dermatology, & other critical therapeutic areas
Reduction observed in RSV-related hospitalizations in adults aged ≥60 years 1 An observed reduction in major adverse cardiovascular events* in adults...